Shandong Weigao Group Medical Polymer and its subsidiaries are principally engaged in the research and development, production and sale of single-use medical devices and orthopedic products. Co.'s products are categorized into four major categories namely: single use medical consumables and materials; orthopedic materials and instruments; blood purification consumables; and cardiovascular stents. Co. maintains a customer base of approximately 5,400 healthcare organizations and distributors, including more than 2,700 hospitals, over 400 blood stations, over 700 other medical units and over 1,500 trading companies.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.